Investigation of mechanisms of action involved in the antidepressant-like effect of Trans,trans-farnesol in mice.
Chem Biol Interact
; 386: 110791, 2023 Dec 01.
Article
em En
| MEDLINE
| ID: mdl-37923004
ABSTRACT
This study aimed to investigate, through in vivo and biochemical methodologies, the effect of trans,trans-farnesol (12.5, 25, 50 or 100 mg/kg, p.o.) acute administration, adopting different behavioral and neurochemical parameters associated with an acute induced-depression model in mice. The initial results showed that, the oral treatment with trans,trans-farnesol, at the dose of 100 mg/kg induced a possible antidepressant-like effect in animals subjected to forced swim test (FST) and reserpine-induced akinesia. In addition, it was observed that the compound in question has an effect size and properties similar to imipramine (prototype of tricyclic antidepressants), but devoid of proconvulsant adverse effect. In biochemical assays, the pretreatment with trans,trans-farnesol, at a dose of 100 mg/kg (p.o.), decreased the hippocampal concentration of thiobarbituric acid reactive substances (TBARS) and restored striatal levels of noradrenaline and serotonin in mice subjected to FST. Altogether, these results suggest that trans,trans-farnesol showed a significant antidepressant-like effect, which seems to be mediated by the antagonism of muscarinic cholinergic receptors, reduction of oxidative stress and the modulation of noradrenaline and serotonin content in the central nervous system.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Serotonina
/
Farneseno Álcool
Limite:
Animals
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article